News

Meet the RCSB PDB at ACA 75

07/18 PDB101 News

<I>Collage of RCSB PDB speakers and topics at ACA.</I>Collage of RCSB PDB speakers and topics at ACA.

From July 18-23, RCSB PDB will be at the 75th Annual Meeting of the American Crystallographic Association in Lombard, IL. ACA is the Structural Science Society.

Presentations and activities will include:

  • Friday July 18: Workshop #3 Enhancing PDB Deposition & Validation Practices Workshop. Registration will be available onsite.
  • Friday July 18: Keynote presentation by RCSB PDB Director Stephen K. Burley
  • Friday July 18-Monday July 21: RCSB PDB Exhibit Booth #36. Stop by to say hello and learn about the latest RCSB PDB news
  • Saturday July 19: In the morning session General Interest I, two presentations from our biocuration team: Data Archive Challenge: Transitioning Users to New IDs and Data File Format at the PDB from Brian Hudson Streamlining OneDep Depositions of Multiple Related 3DEM Entries with pdb_extract from Justin Flatt
  • Saturday July 19: In the afternoon session of the Transactions Symposium on AI and Multimethod Approaches, Brinda Vallat will present PDB-IHM: A System for Archiving and Dissemination of integrative structures
  • Monday July 21: In the morning session on Managing High Data Rates in Structural Science, Brinda Vallat will present PDBx/mmCIF Ecosystem: Foundation for FAIR Access to Macromolecular Structure Data and Alison Biester will present Improving Data Representation of Metalloproteins in the PDB
  • Monday Jul 21: Visit Yuhe Liang in the poster session for RCSB PDB: Driving Research and Education Using Experimentally-Determined Structures and Computed Structure Models from Artificial Intelligence/Machine Learning (Poster PS3-16)

The RCSB PDB Poster Prize will also be awarded to recognize a student poster presentation.

July's Molecule of the Month focus on Capturing Beta-Lactamase in Action describes serial femtosecond crystallography (SFX) and X-ray free-electron lasers (XFELs) which will also be discussed at this meeting.

<I>Sulbactam (yellow) is a β-lactamase inhibitor. It is able to bind in the active site and covalently bond to the catalytic serine, preventing BlaC from binding and cleaving new antibiotic substrates. The topmost light blue subunit is shown as semi-transparent to better visualize sulbactam binding.</I>Sulbactam (yellow) is a β-lactamase inhibitor. It is able to bind in the active site and covalently bond to the catalytic serine, preventing BlaC from binding and cleaving new antibiotic substrates. The topmost light blue subunit is shown as semi-transparent to better visualize sulbactam binding.

News Index